Pasquale Rescigno

Division of Clinical Studies, The Institute of Cancer Research, Sutton, UK; Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust Sutton, UK; Department of Clinical Medicine and Surgery, University Hospital and University Federico II, Naples, Italy

Authored articles: